Catalyst Wire Dossier Catalyst Wire Dossier

Nalfurafine hydrochloride orally disintegrating tablet

nalfurafine hydrochloride · Shenyang Sunshine Pharmaceutical Co., LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nalfurafine hydrochloride orally disintegrating tablet, covering 2021-01-28 to 2021-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet [Phase 3]

See pricing